Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Moderna

Covid vaccines should be available to buy privately in UK, scientists say

People not eligible for autumn booster programme should have option to pay for jab, experts argue, amid new wave concerns

The Guardian - UK

Coronavirus FAQ: Is it wiser to get a booster now or wait for the new fall booster?

Maybe it's not a full-blown summer surge but COVID numbers are ticking up. For those with concerns due to personal risk factors or the start of the school year, the booster question is top of mind.

WEKU

For Flagship, Moderna’s COVID-19 vaccine is a tough act to follow

Unorthodox, brash, and sometimes controversial, Flagship Pioneering is looking for its next blockbuster.

Fortune

From analysis to the latest developments in health,
read the most diverse news in one place.

Moderna's Game Over? Not Quite, As Company Boosts Its 2023 Outlook

Moderna raised its outlook for the year on Thursday, predicting $6 billion to $8 billion in Covid vaccine sales. MRNA stock edged down.

Investors Business Daily

Pfizer, Moderna Try To Squeeze Blood From A Stone. Why It Probably Won't Work.

The biggest names in Covid are updating their vaccines for a fall campaign, but that might not bolster Pfizer stock and Moderna stock.

Investors Business Daily

The Most Objective Evidence Shows No Indication That Covid Vaccines Save More Lives Than They Take

Medical journals describe all-cause mortality in randomized controlled trials (RCTs)

Zenger

FDA Violated Own Safety And Efficacy Standards In Approving Covid-19 Vaccines For Children

Evidence the FDA used for those decisions violates at least three safety and efficacy standards from earlier FDA publications

Zenger

Read news from The Economist, FT, and more,
with one subscription

Pfizer and Moderna parent are investing $100M to find the next big drug

"What we are doing now, I don’t think anyone has done so far," Pfizer CEO Albert Bourla says.

Fortune

10 Stocks Will Make You 30% Richer Than Others In A Year: Analysts

Analysts have the typical hopes for the S&P 500 in the next 12 months. But they're especially bullish on a small handful of stocks.

Investors Business Daily

Moderna signs deal to make mRNA vaccines for Chinese market

Moderna Inc. will push toward producing messenger RNA vaccines for China, seeking a foothold in the world’s second-largest pharmaceutical market even as geopolitical tensions rise.

Tribune News Service

A Long-Awaited Vaccine For Lyme Disease is Tantalizingly Close — Here's When It Could Be Available

Over the past twenty years, Lyme disease cases have continued to climb, and we are finally tantalizingly close to another vaccine.

Inverse

UK regulator sued for not investigating Covid vaccine ‘misinformation’

Case brought against General Medical Council for failure to look into claimed links to heart problems and deaths

The Guardian - UK

Health care providers are adding cloud tech, but need to dream bigger

Currently, the application of cloud in the health care space is choppy.

Fortune

Cancer vaccines are already a reality. Here's what you need to know about the cutting-edge technology that could usher in an era of personalized medicine

The concept may seem torn from the plot of some futuristic sci-fi movie, or from the pages of some decades-old utopian novel far ahead of its time. But such wonders of science exist today.

Fortune

Get all your
news in one place.

100’s of premium titles.
One news app.

Zenger

Moderna Stock Rises After FDA Application For Updated Vaccine

Moderna's potential beyond COVID-19 is underappreciated, says analyst Eliana Merle, who upgraded the stock to Buy

StockNews.com

Moderna (MRNA) vs. BioNTech (BNTX): Which Biotech Stock Should You Be Investing In?

Amidst the biotech industry’s rapid growth and notable advancements, let’s analyze which of the two major players, Moderna (MRNA) and BioNTech (BNTX), is a more favorable investment choice in the current uncertain economic climate. Keep reading to find out.

Inverse

mRNA Vaccines Could Revolutionize Cancer Treatment

Here’s a look at the status of mRNA technology's application in cancer and when it might reach patients.

Wales Online

Devastating virus few parents know about hits three babies a day

World-first vaccine trials have now begun in a bid to protect children from CMV

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Growth Stocks Are Back — Analysts Like These 8 The Best

Growth stocks in the S&P 500 are racing back. And analysts are scrambling to choose their favorites.

Insider UK

Scottish Mortgage sees share price fall by a third

Net asset value also fell by more than 17% during a year that has been 'painful for shareholders'

Inverse

These Next-Generation Vaccines Could Upend Cancer Treatment As We Know It

New high-tech vaccines could help combat common yet deadly conditions like cancer and heart disease.

The Walrus

The Vaccine Problem

To better weather future pandemics, the way countries procure vaccines needs to change radically

The New Daily

mRNA technology beat COVID-19, can it do the same for pancreatic cancer?

Half the pancreatic cancer patients in a new clinical trial were alive and cancer free after 18 months. Most usually die within three months.

The Hindu

FDA approves first vaccine for respiratory syncytial virus

The FDA has approved the first vaccine for respiratory syncytial virus (RSV).

Kiplinger

Moderna Stock Pops on Surprise Earnings Beat

An unexpected profit and promising news on a deal with the EU boosted Moderna stock.

1 … 10 11 12 13

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Warner Bros Discovery

666 stories

SP Global Market Intelligence

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.